Publications by authors named "D H Adda"
Article Synopsis
- The introduction of direct-acting antivirals (DAAs) offers hope for eliminating hepatitis C virus (HCV) by 2030, but some patients (2%-12%) experience treatment failure, potentially due to existing drug resistance.
- A systematic review of 56 studies found a high prevalence of hepatitis C resistance-associated substitutions (RAS) among patients with virological failure after DAA treatment, ranging from 78% to 100% depending on the specific treatment regimen.
- The findings highlight the importance of monitoring DAA-associated resistance and understanding its implications for future treatment strategies.
Over 250 million individuals live with chronic hepatitis B (CHB) infection worldwide. A significant proportion of these people often face discrimination defined as the unjust, unfair, or prejudicial treatment of a person on the grounds of their hepatitis B status. Hepatitis B related discrimination has not been widely documented in the literature.
View Article and Find Full Text PDFArticle Synopsis
- Chronic hepatitis B infection (CHB) affects 300 million people and is part of a global effort by the United Nations and WHO to eliminate it as a health threat by 2030.
- Peer support workers (PSWs) are people who have experienced similar health issues and can help others by providing education and emotional support, especially for those with CHB.
- Investing in peer support can help improve healthcare access, reduce stigma, and ultimately contribute to the goal of eliminating hepatitis B around the world.
Article Synopsis
- * In early 2023, a survey was done with 560 people who have hepatitis B to understand their healthcare experiences and preferences for treatment and care.
- * The results showed that many people don’t see a doctor regularly for check-ups, want to be more involved in their care decisions, and face challenges with getting affordable medication and knowledgeable providers.